ClinicalTrials.gg
Not yet recruitingNCT07624253Updated Oct 20, 2026

Mindfulness Psychoeducation Based on Transtheoretical Model for Fear of Childbirth

An interventional study of Mindfulness-Based Psychoeducation in Fear of Childbirth and Pregnancy, sponsored by Nigde Omer Halisdemir University. Not yet recruiting at 1 site in Turkey (Türkiye). Open to female participants aged 18 Years to 40 Years. Per ClinicalTrials.gov, last updated 2026-10-20.

Sponsored by Nigde Omer Halisdemir University · Not applicable, Interventional, and Supportive care

How we know

Updated Oct 20, 2026Start date movedGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
72
Allocation
Randomized
Ages
18 Years to 40 Years
Sex
Female
01

Study summary

Childbirth is a significant life event with important physical and psychological effects on pregnant women. Due to uncertainty during pregnancy, many women experience fear of childbirth. Fear of childbirth is a common condition that may negatively affect maternal well-being. Therefore, various psychosocial interventions have been developed to reduce this condition. Mindfulness-based approaches and psychoeducation programs are considered effective methods for reducing stress, anxiety, and fear by promoting non-judgmental awareness of the present moment.

This study is designed as a randomized controlled experimental trial. The study population will consist of pregnant women attending the Obstetrics and Gynecology Outpatient Clinic of Niğde Ömer Halisdemir Training and Research Hospital who meet the inclusion criteria. The sample size was calculated using G*Power 3.1.9.7 software. Based on an effect size of f = 0.38, 80% statistical power, and a 5% significance level, a minimum of 30 participants was required. Considering a 20% potential dropout rate, a total of 72 pregnant women (36 intervention and 36 control) will be included in the study.

The inclusion criteria are being between 18 and 40 years of age, having a first pregnancy, being between 20 and 34 weeks of gestation, having a singleton and healthy pregnancy, being able to communicate in Turkish, and scoring 38 or higher on the Wijma Delivery Expectancy/Experience Questionnaire (Version A). Women with high-risk pregnancies, a history of psychiatric disorders, illiteracy, communication problems, or unwillingness to participate will be excluded. Withdrawal during the study, development of pregnancy complications, or inability to continue the intervention will be considered exclusion criteria.

Data will be collected using a Sociodemographic Information Form, the Wijma Delivery Expectancy/Experience Questionnaire (W-DEQ A), the Self-Perception Scale for Pregnant Women, and the Spiritual Well-Being Scale. The W-DEQ A measures fear of childbirth, the Self-Perception Scale assesses maternal and body perception during pregnancy, and the Spiritual Well-Being Scale evaluates the level of spiritual well-being.

At the beginning of the study, eligible participants will be informed about the research and written informed consent will be obtained. Data collection forms will first be administered face-to-face. Pregnant women scoring 38 or above on the W-DEQ A will then be randomly assigned to intervention and control groups using a computer-based randomization method (randomizer.org).

The intervention group will receive a mindfulness-based psychoeducation program adapted according to the Transtheoretical Model. The intervention will be delivered in group sessions of 6-10 participants, twice a week for 4 weeks, with each session lasting approximately 45-60 minutes. The program includes psychoeducation about pregnancy and childbirth, mindfulness exercises, emotional awareness activities, and coping strategies for fear of childbirth.

The control group will receive routine obstetric care only. Post-intervention assessments will be conducted in both groups using the same measurement tools.

Data analysis will be performed using SPSS version 25.0. Descriptive statistics will be calculated, and depending on data distribution, independent samples t-test, paired samples t-test, ANOVA, Mann-Whitney U test, Kruskal-Wallis test, and chi-square test will be used. The level of statistical significance will be set at p \< 0.05.

The aim of this study is to evaluate the effect of a mindfulness-based psychoeducation intervention based on the Transtheoretical Model on fear of childbirth, self-perception, and spiritual well-being in pregnant women experiencing fear of childbirth.

02

Conditions studied

  • Fear of Childbirth
  • Pregnancy

Keywords

  • fear of childbirth
  • pregnancy
  • mindfulness
  • psychoeducation
  • self-perception
  • spiritual well-being
03

In context

Lead sponsor

Nigde Omer Halisdemir University is the lead sponsor of 95 studies on the registry; 32 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 40 Years
Sexes eligible
Female
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Willing to participate in the study,
  • Aged between 18-40 years,
  • Primigravida (first pregnancy),
  • Not having received any childbirth preparation class,
  • Scoring 38 or above on the Wijma Delivery Expectancy/Experience Questionnaire,
  • Between 20 and 34 weeks of gestation,
  • Having a healthy pregnancy,
  • Having a singleton pregnancy,
  • Carrying a live fetus,
  • Not in active labor,
  • Able to speak Turkish and without any language, comprehension, or communication problems to understand and answer the questions.

Exclusion criteria

Exclusion Criteria:

  • Those who do not agree to participate in the study,
  • Pregnant women under 18 years of age and over 41 years of age,
  • Diagnosed with high-risk pregnancy,
  • Illiterate,
  • Having a contagious disease,
  • Having a current or past psychiatric disorder requiring treatment,
  • Having mobility, hearing, or psychological disabilities,
  • With a gestational age below 20 weeks or above 32 weeks,
  • Those who have entered active labor.

Withdrawal / Exclusion Criteria

  • Participants who withdraw consent and wish to leave the study during the study period,
  • Participants who are unable to adapt to the intervention process,
  • Participants experiencing communication or internet connectivity problems,
  • Participants who develop complications during the intervention (e.g., onset of labor, decreased fetal movements, etc.) requiring hospitalization will be excluded from the study.
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
72 participants (estimated)

Study arms

  • Experimental
    Mindfulness-Based Psychoeducation Group

    Participants will receive a mindfulness-based psychoeducation program adapted according to the Transtheoretical Model. The intervention will be delivered in groups of 6-10 pregnant women twice a week for 4 weeks in an online format. Each session will last approximately 45-60 minutes. The program includes psychoeducation about pregnancy and childbirth, mindfulness exercises, emotional awareness activities, and coping strategies for fear of childbirth. The aim of the intervention is to reduce fear of childbirth and improve self-perception and spiritual well-being. The intervention will be conducted online to increase participant comfort and accessibility.

    Behavioral: Mindfulness-Based Psychoeducation

  • No intervention
    Control Group

    Participants in this arm will receive routine obstetric care provided by the hospital during pregnancy. No additional psychological, educational, or mindfulness-based intervention will be applied throughout the study period.

Interventions

  • BehavioralMindfulness-Based Psychoeducation

    Participants in this arm will receive a mindfulness-based psychoeducation program adapted according to the Transtheoretical Model. The intervention will be delivered in groups of 6-10 pregnant women twice a week for 4 weeks in an online format. Each session will last approximately 45-60 minutes. The program includes psychoeducation about pregnancy and childbirth, mindfulness exercises, emotional awareness activities, and coping strategies for fear of childbirth. The aim is to reduce fear of childbirth and improve self-perception and spiritual well-being.

06

What researchers measure

Primary outcomes

  1. Fear of childbirth (W-DEQ A score)

    Developed by Wijma et al. in 1988 (Wijma et al., 1998), the scale was adapted into Turkish by Körükçü et al. in 2012. Fear of childbirth will be measured using the Wijma Delivery Expectancy/Experience Questionnaire Version A (W-DEQ A). The scale assesses the fear of childbirth, with higher scores indicating higher levels of fear. The scale consists of 33 items and 6 subscales, utilizing a 6-point Likert-type format (0 = completely, 5 = not at all). The total score obtainable from the scale ranges from a minimum of 0 to a maximum of 165. Scores between 0-37 indicate mild fear, 38-65 indicate moderate fear, 66-84 indicate severe fear, and scores of 85 and above indicate clinical-level fear. In this study, participants scoring 38 or above (corresponding to moderate and severe fear levels) will be included. Measurements will be conducted at baseline (pre-intervention) and immediately after the completion of the intervention.

    Time frame: Baseline and immediately post-intervention

Secondary outcomes

  1. Self-Perception of Pregnant Women

    The Self-Perception of Pregnant Women Scale was developed by Kumcağız et al. in 2017.The scale evaluates maternal perception related to pregnancy, including maternal identity and body image. It consists of 12 items and utilizes a 4-point Likert-type format (4: always, 3: mostly, 2: sometimes, 1: never). The scale comprises two subdimensions: In the "Maternal Perception of Pregnancy" subscale, the maximum obtainable score is 28, and the minimum is 7. Higher scores in this subscale indicate a higher level of positive maternal perception, whereas lower scores indicate a lower level of maternal perception. In the "Body Image of Pregnancy" subscale, the maximum obtainable score is 20, and the minimum is 5. Higher scores in this subscale indicate a more negative body image, whereas lower scores indicate a more positive body image (Kumcağız et al., 2017). Measurements will be conducted at baseline (pre-intervention) and immediately after the completion of the intervention.

    Time frame: Baseline and immediately post-intervention

  2. Spiritual Well-Being

    It is a scale developed by Ekşi and Kardaş in 2017. The scale consists of 29 items across 3 subdimensions: "transcendence", "harmony with nature", and "anomie", and utilizes a 5-point Likert-type format (1 = Not at all suitable for me, 2 = Not suitable for me, 3 = Somewhat suitable for me, 4 = Quite suitable for me, 5 = Completely suitable for me). The total score obtainable from the scale ranges from a minimum of 29 to a maximum of 145. Items in the anomie subdimension are reverse scored. As the total scores increase, spiritual well-being increases. While higher scores in the "transcendence" and "harmony with nature" subscales represent positive spiritual well-being, higher scores in the "anomie" subdimension indicate lower spiritual well-being (Ekşi and Kardaş, 2017). Measurements will be conducted at baseline (pre-intervention) and immediately after the completion of the intervention.

    Time frame: Baseline and immediately post-intervention

07

Study locations

1 site
  • Niğde Ömer Halisdemir Eğitim ve Araştırma Hastanesi
    Niğde, Turkey (Türkiye)
    • Büşra Rümeysa Demirel, PhD Student · Contactbdemirel@ohu.edu.tr · +90 5551964396
    • Gamze Sarıkoç, Associate Professor · Contactgamze.sarikoc@sbu.edu.tr · +90 530 642 23 13
    • Büşra Rümeysa Demirel, PhD Student · Principal investigator
    • Gamze Sarıkoç, Associate Professor · Sub investigator
08

References and documents

Individual participant data

Plan to share: No — Individual participant data (IPD) will not be shared due to ethical and privacy reasons. The dataset contains sensitive health information collected from pregnant women, and sharing IPD could compromise participant confidentiality. The data will be utilized solely for the purposes of this study and will not be made publicly available.

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it moved

Start is estimated for Oct 2026; primary completion for Jan 2027, 3 months later.

Start moved once since we started tracking on Sep 25, 2026: Jul 2026 → Oct 2026, on Oct 20, 2026.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
May 22, 2026
First posted
Jun 3, 2026
StartEst.
Oct 15, 2026was Jul 2026
Primary completionEst.
Jan 15, 2027
CompletionEst.
Jul 15, 2028
Last update
Oct 20, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Start date
Jul 15, 2026→Oct 15, 2026
Oct 20, 2026
Show all 1 update
  1. Oct 20, 2026
    Start date Jul 15, 2026→Oct 15, 2026
    + 2 other changes: responsible party and contact details

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07624253
Lead sponsor
Nigde Omer Halisdemir University
Responsible party
Büşra Rümeysa Eskintan (Research Assistant, Nigde Omer Halisdemir University) — Principal investigator
First posted
Jun 3, 2026
Start date
Oct 15, 2026 (estimated)
Primary completion
Jan 15, 2027 (estimated)
Completion
Jul 15, 2028 (estimated)
Last update
Oct 20, 2026

Study contacts

Büşra Rümeysa Demirel, PhD Student
Contact
bdemirel@ohu.edu.tr
+90 5551964396
Gamze Sarıkoç, Associate Professor
Contact
gamze.sarikoc@sbu.edu.tr
+90 530 642 23 13
Gamze Sarıkoç, Associate Professor
principal investigator · Saglik Bilimleri Universitesi

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in May 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion